Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study.

Yi-Kun KangYi-Ran SiJie JuZhu-Qing JiaNan-Lin HuHao DongXue WangJian YuePei-Di JiangZhao-Liang LiYun-Yun ZhangYan WangBing-He XuPeng Yuan

Published in: Cancer medicine (2022)

Early changes in the plasma HER2 ratio may predict the treatment response in patients with advanced breast cancer and could facilitate optimal treatment selection.

Keyphrases

double blind
cross sectional
young adults
combination therapy
replacement therapy
childhood cancer